Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial

The Lancet Oncology

DOI: 10.1016/s1470-2045(22)00694-5 Full text (OA) OpenAlex

Authors 0

Author list not loaded yet.

Cited by 12 stored of 606

Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2-associated high-risk HER2-negative early breast cancer: updated results from the OlympiA phase III trial
2026 Annals of Oncology article Medicine PARP inhibition in cancer therapy Open access

0

citations
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2026
2026 Breast Care article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access

1

citations
Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study
2025 British journal of surgery article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies

6

citations
Ribociclib–Letrozole Combination as an Alternative for Neoadjuvant Chemotherapy in Selected Postmenopausal Patients with Luminal Breast Cancer (BOOG 2017-01)
2025 Clinical Cancer Research article Medicine Advanced Breast Cancer Therapies Open access

4

citations
Update Breast Cancer 2024 Part 2 – Patients with Early Stage Breast Cancer
2025 Geburtshilfe und Frauenheilkunde article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access

6

citations
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2025
2025 Breast Care article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access

21

citations
Post(neo)adjuvante Therapiekonzepte – Möglichkeiten der Individualisierung
2024 Die Gynäkologie article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies

0

citations
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024
2024 Breast Care article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access

18

citations
Update Mammakarzinom 2023 Teil 3 – Expertenmeinungen zu Brustkrebs in frühen Krankheitsstadien
2023 Senologie - Zeitschrift für Mammadiagnostik und -therapie article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access

0

citations
Update Breast Cancer 2023 Part 3 – Expert Opinions of Early Stage Breast Cancer Therapies
2023 Geburtshilfe und Frauenheilkunde article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access

6

citations
Update Breast Cancer 2023 Part 1 – Early Stage Breast Cancer
2023 Geburtshilfe und Frauenheilkunde article Medicine Advanced Breast Cancer Therapies Open access

5

citations
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023
2023 Breast Care article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access

29

citations

12 results

Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial

Authors 0

Cited by 12 stored of 606

References 0